Abstract PS2-09-26: Circulating microRNA and cytokine signatures associated with interstitial lung disease in patients treated with trastuzumab deruxtecan
M. Alva Bianchi(Research Institute Hospital 12 de Octubre), E. Ciruelos Gil(Research Institute Hospital 12 de Octubre), Laura Lema(Hospital Universitario 12 De Octubre), Cristina Martin-Arriscado(Research Institute Hospital 12 de Octubre), J. Montes(Research Institute Hospital 12 de Octubre), M. Cobos(Research Institute Hospital 12 de Octubre), L. Manso(Research Institute Hospital 12 de Octubre), M. Dueñas(Research Institute Hospital 12 de Octubre), M. Luis(Research Institute Hospital 12 de Octubre), A. Madariaga(Research Institute Hospital 12 de Octubre), W. Parra(Research Institute Hospital 12 de Octubre), P. Tolosa(Research Institute Hospital 12 de Octubre), I. Diaz(Research Institute Hospital 12 de Octubre), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre)
Cited by 0
Related Papers
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60
Chronic opioid therapy in long-term cancer survivors
|Clinical & Translational Oncology|2016|59